Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery

Supplemental Digital Content is available in the text. Objective We sought to describe a technique for ultra-low-contrast angiography (ULCA) in patients with advanced chronic kidney disease (CKD) and previous coronary artery bypass surgery (CABG). Background Patients with advanced CKD and previous CABG are at high risk of developing contrast-induced nephropathy (CIN) because of the additional contrast often required to identify bypass grafts. Apart from hydration, reduced contrast administration is the only established method to minimize the risk of CIN. Patients and methods Ten patients underwent ULCA, whereby an intracoronary injection of saline and coronary guidewires were used instead of test injections of contrast for engagement of bypass grafts with catheters. Estimated glomerular filtration rate (eGFR) before and 30 days following angiography were recorded as was the need for renal replacement therapy 1 year after the procedure. Results All patients completed a diagnostic angiogram without complications. The median volume of contrast delivered was 13.5 ml (interquartile range: 10.5–17.8). The median eGFR was 18.3 ml/min/1.73 m2 (interquartile range: 16.5–28.2). There was no statistically significant difference in eGFR before the procedure and 30 days after the procedure (P=0.79). No patient required dialysis 30 days after the procedure. Two patients required initiation of dialysis at 1 year after the procedure. Conclusion In patients with advanced CKD and previous CABG, ULCA may be performed with high procedural success and without complications, minimizing the risk of CIN in these high-risk patients.

[1]  Guo-li Sun,et al.  Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography. , 2019, Heart, lung & circulation.

[2]  H. Gurm,et al.  Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  Z. Ali,et al.  Zero contrast retrograde chronic total occlusions percutaneous coronary intervention: a case series , 2018, European heart journal. Case reports.

[4]  M. Mosseri,et al.  Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures , 2018, Nephron.

[5]  Z. Ali,et al.  Zero‐contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  Sunil V. Rao,et al.  Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. , 2017, The American journal of cardiology.

[7]  G. Stone,et al.  Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. , 2016, European heart journal.

[8]  P. Thompson,et al.  Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System. , 2016, The Journal of invasive cardiology.

[9]  U. Schoepf,et al.  Contrast-Induced Nephropathy , 2015, Circulation.

[10]  G. Stone,et al.  Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials , 2015, Circulation. Cardiovascular interventions.

[11]  E. Edelman,et al.  Intravascular Ultrasound Guidance to Minimize the use of Iodine Contrast in Percutaneous Coronary Intervention: The MOZART Randomized Controlled Trial , 2014 .

[12]  Somjot S. Brar,et al.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.

[13]  B. Rangan,et al.  A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention). , 2013, JACC. Cardiovascular interventions.

[14]  H. Gurm,et al.  Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions. , 2013, JACC. Cardiovascular interventions.

[15]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[16]  Keshav R. Nayak,et al.  A novel technique for ultra‐low contrast administration during angiography or intervention , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  R. Elosua,et al.  Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. , 2010, Archives of internal medicine.

[18]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[19]  W. Gibler,et al.  Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. , 2006, The American journal of medicine.

[20]  B. Hemmelgarn,et al.  Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.

[21]  B. McNeil,et al.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[22]  Robert M Califf,et al.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.

[23]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.

[24]  G. Stone,et al.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.

[25]  H. K. Pedersen Electrolyte addition to nonionic contrast media. Cardiac effects during experimental coronary arteriography. , 1996, Acta radiologica. Supplementum.